LIPO - LIPELLA PHARMACEUTICALS INC.

2.36
-0.345   -14.619%

Share volume: 310,975
Last Updated: 06-18-2025
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%
$2.70
-0.35
-0.13%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
37%
Profitability 35%
Dept financing 24%
Liquidity 50%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
-7.45%
2 Year
250.36%
Key data
Stock price
$2.36
P/E Ratio 
0.00
DAY RANGE
$2.25 - $2.91
EPS 
-$3.59
52 WEEK RANGE
$1.96 - $3.17
52 WEEK CHANGE
$3.06
MARKET CAP 
2.773 M
YIELD 
N/A
SHARES OUTSTANDING 
4.621 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
11-08-2024
NEXT EARNINGS DATE
04-29-2025
BETA 
1.05
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Jon Kaufman
Region: US
Website: lipella.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Our principal executive offices are located at 7800 Susquehanna Street, Suite 505, Pittsburgh, PA.

Recent news